Clinical Trial Detail

NCT ID NCT01273155
Title Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

lymphoma

Advanced Solid Tumor

Therapies

Belinostat

Age Groups: adult senior

No variant requirements are available.